Definitive Contract 75D30122C14450
Award Date
8/3/22
Potential Completion Date
11/30/24
Potential Value
$884K
Federal Agency
CDC Pittsburgh
Awardee
Abcellera Biologics Inc.
Ultimate Awardee
Not listed
PSC Category
8820 - Live Animals, Not Raised For Food
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abclonal Science, Inc. (doing business as Abclonal Technology), a foreign-owned, self-certified small disadvantaged business. The $246,880.00 firm-fixed-price purchase order is for gene synthesis antibodies, with a completion date of August 30, 2020. The contract does not have a set-aside designation. Based on the agency and description, this contract...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,971.50 firm fixed price purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185806). As the prime contractor, Cyagen Biomodels LLC will deliver the requested mouse models from its facility in Santa Clara, California under the terms of this contract over a six-month period concluding in March 2024. The award...
This firm fixed price purchase order, valued at $60,000, was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Leveragen Inc. of Worcester, Massachusetts. Under this contract, Leveragen will generate two lines of mice with specific CRISPR gene edits to the CTCF gene, containing either an R448Q mutation or a GRP>AAA mutation in amino acids 662-664. This work directly continues the solicitation to develop broadly neutralizing nanobodies...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $28,590.00 firm fixed-price purchase order contract to Abveris, Inc. to provide hybridoma generation cell panel services using mice. This sole-source contract was issued under the authority of 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, as no other source could provide the required proprietary Abveris hyperimmune DiversimAb mice and associated services. The contract...
This federal contract award, valued at $248,779.00, was issued by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, to conduct follow-up testing for tumorigenicity and oncogenicity on the Master Cell Bank (MCB) of Expi293F cells. The contract is a firm-fixed-price purchase order with a completion date of September 24, 2026. The original sources sought notice indicates that the CDC Influenza Division requires cGMP-grade cell...
This federal contract award, valued at $3,869.87, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the procurement of mouse antibodies, which are likely to support various biomedical research and public health initiatives at NIAID and other agencies within the Department of Health and Human Services (HHS)....
This is a $19,134,687.00 definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to MedImmune Biologics, Inc. on December 18, 2015. The contract is for the 2016 Pandemic Influenza Preparedness program, with a period of performance ending on February 28, 2017. The contract does not have a set-aside designation. As the prime contractor, MedImmune Biologics, Inc. will be responsible for delivering the requested products and services under this contract....
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185291). Under the firm fixed price contract, Cyagen Biomodels LLC will deliver conditional knockout mouse models to support the NIH's research efforts from its facility in Santa Clara, California. The contract term runs from September 6, 2023 through...
This is a $35,850 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Jackson Laboratory, a non-profit biomedical research institution located in Bar Harbor, Maine. The contract is for the delivery of MICE research animals and associated husbandry services to support the CDC's public health research initiatives. The contract does not have a set-aside designation. The Jackson Laboratory is a well-established provider of research animals and...